Automated Viral Vector Production System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for producing viral vectors are expensive, time-consuming, and cumbersome, with low yield and high plasmid DNA requirements, making them unsuitable for most therapeutic applications, especially for small-scale production where cost, reproducibility, and sterility are critical.
Innovation Solution
An automated, fully enclosed cell engineering system is used to introduce engineered viral producer cells, transduce them with a vector encoding a gene of interest, expand, and produce viral vectors, followed by downstream processing and purification in a closed and automated process, allowing for controlled and reproducible production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional manual methods are used for viral vector production, then flexibility in operation is maintained, but production cost increases and productivity decreases
Solution Approach 1:
The system performs automated cell transduction, expansion, and viral vector production without manual intervention. The automated transducer delivers transduction factors to cells, and the system automatically monitors and maintains culture conditions, allowing the biological system to serve itself through automated control mechanisms.
Solution Approach 2:
Manual mechanical operations (pipetting, cell handling, media changes) are replaced with an automated robotic system that uses electronic control, automated fluid handling, and computerized monitoring to perform all production steps, thereby increasing productivity while managing complexity through integration.
2Manufacturing precision
If traditional production methods are used, then process simplicity is maintained, but manufacturing precision and product consistency deteriorate
Solution Approach 1:
The system uses a fully enclosed automated transducer and culture environment that maintains sterile, controlled conditions throughout the production process. This inert environment prevents contamination and variability, ensuring consistent manufacturing outcomes while the enclosed design integrates multiple control functions.
Solution Approach 2:
The system incorporates automated monitoring that tracks cell health, culture conditions, and production parameters in real-time, using feedback control to maintain optimal conditions and ensure consistent viral vector production across batches.
3Loss of time
If manual production processes are used, then operational flexibility is maintained, but loss of time in production increases
Solution Approach 1:
The automated system enables continuous operation where cell transduction, expansion, and viral vector production proceed without interruption. The automated transducer continuously delivers factors, and the system maintains continuous culture conditions, eliminating downtime between manual operations and significantly reducing total production time.
4Productivity
If traditional methods are used for viral vector production, then plasmid DNA requirements are reduced, but vector yield decreases
Solution Approach 1:
The system extracts and eliminates the need for large amounts of plasmid DNA by using an automated transducer to deliver transduction factors directly to cells. This removes the requirement for plasmid transfection, thereby increasing viral vector yield without the constraint of plasmid DNA quantity.
Data Source
AI summary
The present disclosure provides an automated method of producing viral vectors, utilizing engineered viral vector-producing cell lines, or packaging cells, within a fully-enclosed cell engineering system. Exemplary viral vectors that can be produced include lentivirus vectors, adeno-associated virus vectors, baculovirus vectors and retrovirus vectors.